News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boehringer Ingelheim Corporation and Eli Lilly and Company (LLY) Release: New Poll Highlights Treatment Priorities of European Primary Care Physicians When Managing Type 2 Diabetes


9/23/2013 9:46:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

INGELHEIM, Germany & INDIANAPOLIS, Ind.--(BUSINESS WIRE)--Boehringer Ingelheim and Eli Lilly and Company today announced results from a poll conducted with more than 1,000 primary healthcare professionals (HCPs) across eight European countries surveyed on their current perceptions and challenges in treating people with Type 2 Diabetes (T2D) across Europe.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES